SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001104659-21-005634
Filing Date
2021-01-20
Accepted
2021-01-20 07:18:07
Documents
2
Effectiveness Date
2021-01-20

Document Format Files

Seq Description Document Type Size
1 S-3MEF tm213363d3_s3mef.htm S-3MEF 48846
2 EXHIBIT 23.1 tm213363d3_ex23-1.htm EX-23.1 1867
  Complete submission text file 0001104659-21-005634.txt   51739
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-252246 | Film No.: 21537391
SIC: 2834 Pharmaceutical Preparations